For Immediate Release:
Statement From:

Janet Woodcock, M.D.
Acting
Commissioner of Food and Drugs – Food and Drug Administration

Mitch Zeller, JD
Director – Center for Tobacco Products

The following is attributed to Acting FDA Commissioner Janet Woodcock, M.D., and Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products

On this day last year, the U.S. Food and Drug Administration faced the unprecedented task of reviewing applications for over 6.5 million “deemed” new tobacco products – many of which were already on the market. A majority of the applications submitted by a court-ordered deadline of Sept. 9, 2020, were for electronic nicotine delivery systems (ENDS) products, such as e-cigarettes and e-liquids, which had never been through the FDA review process. 

We’ve made significant progress in the months since, working diligently to better understand these products and, as of today, taking action on about 93% of